144 related articles for article (PubMed ID: 22001702)
1. [Cost of functioning of a centralised pharmaceutical unit: evaluation of mean costs of chemotherapy preparations according to the level of production of the unit].
Galy G; Bauler S; Buchi M; Pirot F; Pivot C
Bull Cancer; 2011 Oct; 98(10):1153-63. PubMed ID: 22001702
[TBL] [Abstract][Full Text] [Related]
2. Reusing cytostatics in a centralised pharmacy preparation unit.
Ramos Linares S; Merino Alonso J; Román González N; Tévar Alfonso E; Díaz Ruíz P; Gorchs Molist M
Farm Hosp; 2011; 35(2):70-4. PubMed ID: 20869287
[TBL] [Abstract][Full Text] [Related]
3. [Economical assessment of intravenous mixture centralization].
Martínez-Tutor MJ
Farm Hosp; 2006; 30(6):351-8. PubMed ID: 17298192
[TBL] [Abstract][Full Text] [Related]
4. [Costs of a cytostatic drug preparation unit in a hospital in Mexico].
Martínez Rodríguez OA; Rivas Bocanegra RE; Ascencio-Pérez IS; Zapata Sánchez LA
Farm Hosp; 2007; 31(6):375-8. PubMed ID: 18348668
[TBL] [Abstract][Full Text] [Related]
5. Financial perspectives for the staff pharmacist.
Klepcyk JC
Top Hosp Pharm Manage; 1989 Aug; 9(2):39-48. PubMed ID: 10318295
[No Abstract] [Full Text] [Related]
6. Effect of requiring advance approval of chemotherapy on number and cost of ungiven doses.
Berhoune M; Aboudagga H; Jacob A; Grandhaye JP; Dayot C; Prognon P; Bonan B
Am J Health Syst Pharm; 2011 Apr; 68(7):557-8. PubMed ID: 21411796
[No Abstract] [Full Text] [Related]
7. Economic assessment of aseptic compounding rooms in hospital pharmacies in five European countries.
Dekyndt B; Décaudin B; Lannoy D; Odou P
J Oncol Pharm Pract; 2015 Apr; 21(2):102-10. PubMed ID: 24519187
[TBL] [Abstract][Full Text] [Related]
8. Personnel requirements for improving services in a hospital pharmacy.
Harsfield JC; Kaul AF
Hosp Pharm; 1978 May; 13(5):264, 266-7, 301. PubMed ID: 10307641
[TBL] [Abstract][Full Text] [Related]
9. Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs.
Nerich V; Borg C; Villanueva C; Thiery-Vuillemin A; Helias P; Rohrlich PS; Demarchi M; Pivot X; Limat S
J Oncol Pharm Pract; 2013 Mar; 19(1):8-17. PubMed ID: 22623276
[TBL] [Abstract][Full Text] [Related]
10. Centralized intravenous additive services (CIVAS): the state of the art in 2010.
Hecq JD
Ann Pharm Fr; 2011 Jan; 69(1):30-7. PubMed ID: 21296215
[TBL] [Abstract][Full Text] [Related]
11. [The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization].
Zuziak S; Topór-Madry R; Pilc A; Bochenek T
Pol Merkur Lekarski; 2014 Jul; 37(217):43-8. PubMed ID: 25154199
[TBL] [Abstract][Full Text] [Related]
12. Monitrend II offers third-quarter operations data.
Health Facil Manage; 1992 Mar; 5(3):58-9. PubMed ID: 10117513
[No Abstract] [Full Text] [Related]
13. Impact of the implementation of vasoactive drug protocols on costs in the treatment of critically ill patients.
Cuesta-López I; Sánchez-Cuervo M; Candela-Toha Á; Benedí-González J; Bermejo-Vicedo T
Farm Hosp; 2018 Mar; 42(2):62-67. PubMed ID: 29501057
[TBL] [Abstract][Full Text] [Related]
14. A preliminary analysis of the reduction of chemotherapy waste in the treatment of cancer with centralization of drug preparation.
Hyeda A; Costa ES
Rev Assoc Med Bras (1992); 2015 Aug; 61(4):368-74. PubMed ID: 26466220
[TBL] [Abstract][Full Text] [Related]
15. A centralized intravenous additive system in an Israeli government hospital.
Lustig A
Isr J Med Sci; 1993; 29(2-3):89-93. PubMed ID: 8468177
[TBL] [Abstract][Full Text] [Related]
16. [Centralized compounding of cytostatics results in better service and lower cost].
Eklund LH; Juneskans OT; Mellstedt H; Montelius C
Lakartidningen; 1991 Mar; 88(12):1108-9. PubMed ID: 1901929
[No Abstract] [Full Text] [Related]
17. Cost-benefit of a clinical services integrated with a decentralized unit dose system.
Warrian K; Irvine-Meek J
Can J Hosp Pharm; 1988 Jun; 41(3):109-12. PubMed ID: 10312603
[TBL] [Abstract][Full Text] [Related]
18. Impact of robotic antineoplastic preparation on safety, workflow, and costs.
Seger AC; Churchill WW; Keohane CA; Belisle CD; Wong ST; Sylvester KW; Chesnick MA; Burdick E; Wien MF; Cotugno MC; Bates DW; Rothschild JM
J Oncol Pract; 2012 Nov; 8(6):344-9, 1 p following 349. PubMed ID: 23598843
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of hospital pharmacy practice in Indiana.
Kirk KW; Losey MM; Choich R; Kiepert DR
Am J Hosp Pharm; 1978 Jul; 35(7):802-5. PubMed ID: 665697
[TBL] [Abstract][Full Text] [Related]
20. Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation.
Adade CA; Benabbes M; Belahcen MJ; Rahali Y
J Oncol Pharm Pract; 2020 Oct; 26(7):1630-1636. PubMed ID: 32046581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
